Effectiveness Of Natrum Muriaticum In Reducing Symptoms Of Depressive Episode

Effectiveness Of Natrium Muriaticum In Reducing The Symptoms Of Depressive Episode

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040888

Enrollment

Registered

2022-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F340- Cyclothymic disorder Health Condition 2: F341- Dysthymic disorder Health Condition 3: F334- Major depressive disorder, recurrent, in remission Health Condition 4: F330- Major depressive disorder, recurrent, mild Health Condition 5: F331- Major depressive disorder, recurrent, moderate Health Condition 6: F325- Major depressive disorder, singleepisode, in full remission Health Condition 7: F324- Major depressive disorder, singleepisode, in partial remission Health Conditi

Interventions

Intervention1: Homoeopathic Medicine[Natrum Muriaticum]: Natrum muriaticum is prescribed according to homoeopathic principles. Natrum muriaticum will select when it is comes within the first five posi

Eligibility

Inclusion criteria

Inclusion criteria: Cases satisfying Depressive episode diagnostic criteria of ICD10 Diagnostic Criteria for Research. Age group between 18 to 60 years. The cases in which Natrum Muriaticum comes up within the first five position according to repertorization result Recurrent depressive episode

Exclusion criteria

Exclusion criteria: Depressive patients with severe suicidal ideation, with a history of attempted suicide Mood disturbances when associated with schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder otherwise specified Any other conditions requiring emergency or surgical intervention Subjects who are pregnant or lactating. Severe systemic illness using conventional treatment. Bipolar affective disorder

Design outcomes

Primary

Measure	Time frame
To determine the effectiveness of Natrum Muriaticum in reducing the symptoms of Depressive episode by using HDRS 17 scale.Timepoint: 1 year	—

Secondary

Measure	Time frame
To find out changes in quality of life of patient with respect to the Natrum Muriaticum by using WHO QOL BREFTimepoint: 1 year follow up	—

Countries

India

Contacts

Public ContactDr DEEPTHI GILLA

Kerala University Of Health Sciences

drdeepthigilla@gmail.com8111990221

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026